Top Stock Picks 2025: As 2024 comes to a close, the stock market is gearing up for what promises to be an exciting 2025. Major benchmark indices like Nifty ended 2024 with a 10% rise, and market experts expect a mix of performances for the upcoming year. Several brokerage firms have shared their stock recommendations for 2025, aiming to offer lucrative investment opportunities for long-term investors. In this article, we look at the top 10+ stocks that are likely to make significant strides in 2025, according to leading brokerage firms.
Top Stock Picks for 2025: Axis Securities Recommendations
1. Shriram Finance
- Current Market Price (CMP): ₹2,930
- Target Price (TGT): ₹3,825
- Upside Potential: 31%
Shriram Finance is expected to see substantial growth in the coming year, driven by its strong fundamentals and financial sector performance.
2. Fortis Healthcare
- CMP: ₹672
- TGT: ₹860
- Upside Potential: 28%
As the healthcare sector continues to boom, Fortis Healthcare is well-positioned for significant growth, offering good upside potential.
3. Prestige Estates Projects
- CMP: ₹1,748
- TGT: ₹2,195
- Upside Potential: 26%
This real estate company is expected to benefit from increased demand in the residential and commercial sectors, making it a strong pick for 2025.
4. City Union Bank
- CMP: ₹174
- TGT: ₹215
- Upside Potential: 24%
With a solid financial foundation, City Union Bank offers promising returns in the banking sector.
5. Ethos
- CMP: ₹3,112
- TGT: ₹3,750
- Upside Potential: 21%
Ethos, a luxury watch retailer, is poised for steady growth in the luxury goods market, making it an attractive option for investors.
6. Ambuja Cement
- CMP: ₹550
- TGT: ₹675
- Upside Potential: 23%
As the construction sector recovers, Ambuja Cement stands to gain, with strong growth prospects in the cement industry.
7. Doms Industries
- CMP: ₹2,553
- TGT: ₹3,120
- Upside Potential: 22%
Doms Industries is expected to see steady growth in its sector, making it a valuable stock for 2025.
8. Bharti Airtel
- CMP: ₹1,600
- TGT: ₹1,880
- Upside Potential: 18%
The telecom giant is set to benefit from the growing demand for 5G services and is expected to see a positive performance in 2025.
9. Cipla
- CMP: ₹1,489
- TGT: ₹1,735
- Upside Potential: 17%
Cipla, a leader in the pharmaceutical industry, is expected to perform well due to its strong portfolio and growth in healthcare.
Bajaj Broking’s Stock Suggestions
10. Prestige Estates
- Buy Range: ₹1,810 – ₹1,880
- TGT: ₹2,290
- Upside Potential: 24%
Prestige Estates continues to be a top pick for real estate investors, with solid growth expected in the coming months.
11. HUDCO
- Buy Range: ₹238 – ₹249
- TGT: ₹314
- Upside Potential: 29%
HUDCO’s strong performance in the infrastructure sector gives it high growth potential for 2025.
12. Laurus Labs
- Buy Range: ₹555 – ₹575
- TGT: ₹710
- Upside Potential: 26%
Laurus Labs is expected to thrive in the pharmaceutical sector, providing investors with significant upside potential.
13. Himadri Specialty Chemical
- Buy Range: ₹525 – ₹545
- TGT: ₹687
- Upside Potential: 28%
With a growing demand for specialty chemicals, Himadri is well-positioned for growth in 2025.
14. ITD Cementation
- Buy Range: ₹498 – ₹518
- TGT: ₹670
- Upside Potential: 32%
ITD Cementation offers one of the highest upside potentials among stock recommendations, benefiting from infrastructure projects in India.
4. Conclusion
With 2025 on the horizon, these top 10+ stocks are recommended by leading brokerages for investors seeking strong returns in the coming year. Whether you’re looking for exposure to the healthcare, telecom, banking, or real estate sectors, these stocks offer promising growth potential. Be sure to consider your investment strategy and consult a financial advisor before making decisions based on these picks.
Also Read
PFC Dividend Announcement: Will It Break the ₹580 Record?
₹1900 Crore Market Cap Firm Secures ₹2000 Crore Order – A Stock to Watch!
JSW Energy Secures Major 400 MW NTPC Project – A Stock Worth Watching!
The information provided here is ai generated and for general information and educational purposes only. It is not intended to be personalized investment advice, nor should it be considered as a solicitation to buy or sell any security or financial product.